Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Operating Expenses | 4,693 | 3,859 | 4,471 | 4,317 | 2,732 |
| Operating Income | -4,693 | -3,859 | -4,471 | -4,317 | -2,732 |
| Interest Expense | 95 | 1 | 0 | 0 | 0 |
| Other Income | -14,405 | 767 | 1,294 | -522 | 0 |
| Pre-tax Income | -19,193 | -3,093 | -3,177 | -4,839 | -2,732 |
| Income Tax | 2 | 2 | 2 | 2 | 3 |
| Net Income Continuous | -19,194 | -3,094 | -3,178 | -4,841 | -2,734 |
| Net Income | $-19,194 | $-3,094 | $-3,178 | $-4,841 | $-2,734 |
| EPS Basic Total Ops | -40.00 | -27.50 | -42.50 | -72.50 | -67.50 |
| EPS Basic Continuous Ops | -39.61 | -27.72 | -41.93 | -71.45 | -66.41 |
| EPS Diluted Total Ops | -40.00 | -27.50 | -42.50 | -72.50 | -67.50 |
| EPS Diluted Continuous Ops | -39.61 | -27.72 | -41.93 | -71.45 | -66.41 |
| EPS Diluted Before Non-Recurring Items | -40.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-4,632 | $-3,821 | $-4,404 | $-3,722 | $-2,730 |